A Comparison Between Corifollitropin Alfa and Recombinant FSH for Follicular Recruitment in Women With Polycystic Ovaries Who Undergo IVM Treatment

Trial Profile

A Comparison Between Corifollitropin Alfa and Recombinant FSH for Follicular Recruitment in Women With Polycystic Ovaries Who Undergo IVM Treatment

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Corifollitropin alfa (Primary) ; Follitropin beta
  • Indications Polycystic ovary syndrome
  • Focus Therapeutic Use
  • Acronyms Elonva_IVM
  • Most Recent Events

    • 24 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.
    • 08 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Sep 2017.
    • 28 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top